to provide proportional amounts of key binding partners, except in HEK 293T cells were transfected with: 2.5 µg hFLAG-LRP6, 640 ng Mesd, 18 ng mFz8, 260 ng hAxin, 100 ng GSK3β, 100 ng GFP, 2.5 µg FLAG-LRP6-∆E1-4. All transfections were performed with FuGene6 transfection reagent (Roche), and cells were harvested 24 hours post transfection.
For RNAi knock-down of Drosphila Dsh, S2R+ cells were transfected with 100ng pAc5.1-hLRP6 in 6-well format using effectene reagent (Qiagen) and plated in 96 wells with 1 µg dsRNA the next day, as previously described (1). After 5 days incubation with dsRNA, cells were treated for 1h with control or Wnt3a conditioned media and lysed in cholate buffer (1 % Na cholate, 50 mM Tris-HCl pH 7.0, 150 mM NaCl, 10 mM NaF, 5 mM Na 2 VO 4 , 1 mM PMSF and protease inhibitors). Lysates were analyzed by SDS-PAGE and immunoblot.
For siRNA knock-down of murine Dvl1,2,3 proteins, MEFs in 12-well plate were transfected with a 100 nM mixture of siRNA SmartPools (Dharmacon) targeting all 3 murine dvl transcripts using Dharmafect 1, according to manafacturer's protocol. 60 h after transfection, cells were treated for 15 min with control or Wnt3a medium, harvested in 0.5 ml low salt buffer (5 mM HEPES, pH 6.8, 1 mM MgCl 2 , 10 mM sodium pyrophosphate, 10 mM NaF, 5 mM Na 2 VO 4 , 1 mM PMSF and protease inhibitors) and homogenized with 50 Dounce strokes. Nuclei were removed by centrifugation (5 min, 500g) and membranes pelleted (20 min, 13,000 rpm in a microfuge). Pellets were dissolved in cholate buffer and subjected to SDS-PAGE followed by immunoblot analysis.
For siRNA knock-down of human Dvl1,2,3, HEK 293T cells were transfected in 96-well plates in triplicates with a 50 nM mixture of siRNAs against dvl1, dvl2 and dvl3 and 50 nM siRNAs against β-catenin and non-targeting control siRNAs (Dharmacon) using Dharmafect 1 transfection reagent (Dharmacon). 24 h later, a luciferase reporter assay was carried out using Samples were normalized to beta actin.
Immunoflorescence, imaging and antibodies
Phosphorylated LRP6 was detected with Tp1479 antibody (1), total LRP6 was detected with T1479 antibody (1), Dvl2 was detected with antibody kindly provided by M. Semenov (2), and
Axin antibody was kindly provided by R. Nusse. EEA1, TGN38, Calnexin and GSK3β
antibodies, BD Bioscience; Cy3 conjugated anti-rabbit, FITC-conjugated anti-mouse, anti-GFP antibodies, Dianova; Anti-rabbit Alexa488, anti-rabbit Alexa546, Molecular Probes; monoclonal anti-FLAG M2, Sigma. Dextran Texas Red 10000 MW, lysine fixable was purchased form
Invitrogen.
For HeLa and HEK 293T immunofluorescence staining, cells were treated 21h after transfection with Wnt3a or control conditioned medium for 3 hours before harvest, unless indicated otherwise. Cells were then processed as described (3). P19 cells were processed 24 hours after plating and treated for 2 hours with Wnt3a or control conditioned medium before harvest. For detection of endogenous LRP6 in P19 cells, an antigen retrieval method was used. Prior to antibody incubation, cells were microwave irradiated (90 W) for 3 min in 2.5mL 10mM sodium citrate pH 6.0 and 0.05% Tween 20 (Sigma), left for 20 min to cool at RT and blocked with 1% BSA in PBS. For colocalization of endogenous LRP6 and Dvl2, or LRP6 and Axin proteins, a protocol was used that allows double antigen detection with two antibodies raised in rabbit (4, 5) .
P19 cells, after T1479 and anti-rabbit Alexa488 staining as described (3) (Sigma). Incubation with the primary antibodies Tp1479 overnight at 4°C was followed by antirabbit Alexa488 for 3 h at room temperature and Hoechst staining.
To permit double antigen detection with two antibodies raised in rabbit, after Tp1479 and antirabbit Alexa488 staining, explants were further blocked with 0.5% rabbit serum and unconjugated goat anti-rabbit IgG Fab fragments (1:20) for 1h respectively at room temperature.
Explants were then post-fixed with 4% PFA for 15min at room temperature and microwave irradiated (630W) 6 times for 6.5min in 50mL 10mM sodium citrate (pH6.0) (with 1L tap water in the microwave tray) (4, 5 
Sucrose gradient sedimentation and coimmunoprecipitation
About 20 hours post transfection, HEK 293T cells were treated for 3 hours with Wnt3a or control conditioned medium. MEF cells were treated with 4 µM epoxomicine (Sigma) for 3 hours, and Wnt3a or control conditioned medium for 1 hour before harvest.
Cells were harvested in Hank's Balanced Salt Buffer on ice, pelleted, and lysed for 20 min in extraction buffer: 30 mM Tris (pH 7.3), 140 mM sodium chloride, 1% Triton X-100 (Sigma), 25 mM sodium fluoride, 3mM sodium ortho-vanadate, 2 mM PMSF, 100 nM okadaic acid and protease inhibitor cocktail tablete (Roche). Lysates were centrifuged, and supernatant was layered on top of a 15-40% sucrose gradient in 30 mM Tris (pH 7.3), 140 mM sodium chloride, 0.02% Triton X-100, 25 mM sodium fluoride, 3mM sodium ortho-vanadate and protease inhibitors.
Ultracentrifugation was done in a Beckman SW60 rotor at 43.000 rpm, 4 hours, 4°C. After centrifugation, fractions were collected from the bottom of the tube using a peristaltic pump and analyzed by SDS-PAGE and immunoblot.
For coimmunoprecipitation fractions were pooled, sucrose was diluted by adding 400 µl extraction buffer to 800 µl sample, and incubated for 4 h with FLAG M2 beads (Sigma) at 4°C.
After washing with extraction buffer, proteins were eluted with Laemmli SDS-PAGE loading buffer at 50°C for 10 min. 
